Amplia Therapeutics (Amplia Therapeutics) Price-to-Operating-Cash-Flow : (As of May. 01, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Amplia Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-05-01), Amplia Therapeutics's share price is $0.0487. Amplia Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02. Hence, Amplia Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Amplia Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

INNMF's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.12
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Amplia Therapeutics's Cash Flow from Operations per share for the six months ended in Sep. 2023 was $-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 10.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 19.60% per year.

During the past 10 years, Amplia Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 54.20% per year. The lowest was -29.10% per year. And the median was 11.60% per year.

Amplia Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Amplia Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplia Therapeutics Price-to-Operating-Cash-Flow Chart

Amplia Therapeutics Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Amplia Therapeutics Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Amplia Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Amplia Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amplia Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amplia Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Amplia Therapeutics's Price-to-Operating-Cash-Flow falls into.

Amplia Therapeutics Price-to-Operating-Cash-Flow Calculation

Amplia Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.0487	/	-0.019
	=

Amplia Therapeutics's Share Price of today is $0.0487.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Amplia Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Amplia Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Amplia Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplia Therapeutics (Amplia Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amplia Therapeutics Ltd (OTCPK:INNMF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ATX:Australia

Address

350 Queen Street, Level 17, Melbourne, VIC, AUS, 3000

Website

https://www.ampliatx.com

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Amplia Therapeutics (Amplia Therapeutics) Headlines

From GuruFocus

FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US

By PRNewswire • 01-18-2024

AACR OVARIAN CANCER CONFERENCE PRESENTATION

By PRNewswire • 10-09-2023

AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer

By PRNewswire PRNewswire • 05-29-2023